日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Activity of direct KRAS(G12C) inhibitors in preclinical models of pediatric cancer.

直接 KRAS(G12C) 抑制剂在儿童癌症临床前模型中的活性。

Price Hannah E, Stauffer Stacey, Lee Hyun, Isanogle Kristine A, Wu Ying, Powell Katie, Baker Andrew, Stauffer Lucas, Perciaccante Andrew J, Jewell Connor P, Hernandez Edjay R, Aljabri Ashwaq K, Odeniyide Patience, Pratilas Christine A, Burgan William, Edmondson Elijah F, Difilippantonio Simone, Kortum Robert L, Shern Jack F, Jenkins Lisa M, Rossman Kent L, Yohe Marielle E

A CSF-1R inhibitor both prevents and treats triple-negative breast cancer brain metastases in hematogenous preclinical models.

CSF-1R 抑制剂在血液传播的临床前模型中既能预防又能治疗三阴性乳腺癌脑转移

Zhang Wei, Rahman Samiur, Wu Alex M L, Isanogle Kristine, Robinson Christina, Kumar Dinesh, Khan Imran, Wei Debbie, Zimmer Alexandra S, Fujii Takeo, Difilippantonio Simone, Lipkowitz Stanley, Steeg Patricia

Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma

利用DNA依赖性蛋白激酶(DNA-PK)抑制剂提高尤文氏肉瘤临床前模型中标准化疗的疗效

Collins, Victor J; Ludwig, Katelyn R; Nelson, Ariana E; Sundara Rajan, Soumya; Yeung, Choh; Vulikh, Ksenia; Isanogle, Kristine A; Mendoza, Arnulfo; Difilippantonio, Simone; Karim, Baktiar O; Caplen, Natasha J; Heske, Christine M

Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in Neuroblastoma

RAF/MEK/ERK 和 IGF1R/AKT/mTOR 抑制对神经母细胞瘤的临床前治疗效果

Stacey Stauffer, Jacob S Roth, Edjay R Hernandez, Joshua T Kowalczyk, Nancy E Sealover, Katie E Hebron, Amy James, Kristine A Isanogle, Lisa A Riffle, Lilia Ileva, Xiaoling Luo, Jin-Qiu Chen, Noemi Kedei, Robert L Kortum, Haiyan Lei, Jack F Shern, Joseph D Kalen, Elijah F Edmondson, Matthew D Hall, 

The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models

曲美替尼和甘尼妥单抗联合治疗 RAS 突变 PAX 融合阴性横纹肌肉瘤模型有效

Katie E Hebron, Xiaolin Wan, Jacob S Roth, David J Liewehr, Nancy E Sealover, William J E Frye, Angela Kim, Stacey Stauffer, Olivia L Perkins, Wenyue Sun, Kristine A Isanogle, Christina M Robinson, Amy James, Parirokh Awasthi, Priya Shankarappa, Xiaoling Luo, Haiyan Lei, Donna Butcher, Roberta Smith

Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma

FGFR 家族抑制剂 Futibatinib 治疗儿童横纹肌肉瘤的临床前评估

Jerry T Wu, Adam Cheuk, Kristine Isanogle, Christina Robinson, Xiaohu Zhang, Michele Ceribelli, Erin Beck, Paul Shinn, Carleen Klumpp-Thomas, Kelli M Wilson, Crystal McKnight, Zina Itkin, Hiroshi Sotome, Hiroshi Hirai, Elizabeth Calleja, Volker Wacheck, Brad Gouker, Cody J Peer, Natalia Corvalan, Da

Aging and CNS Myeloid Cell Depletion Attenuate Breast Cancer Brain Metastasis

衰老和中枢神经系统髓系细胞耗竭可减弱乳腺癌脑转移

Alex Man Lai Wu, Selamawit Gossa, Ramakrishna Samala, Monika A Chung, Brunilde Gril, Howard H Yang, Helen R Thorsheim, Andy D Tran, Debbie Wei, Esra Taner, Kristine Isanogle, Yuan Yang, Emma L Dolan, Christina Robinson, Simone Difilippantonio, Maxwell P Lee, Imran Khan, Quentin R Smith, Dorian B McG

Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma

Rigosertib 诱导 RAS 突变横纹肌肉瘤和神经母细胞瘤的有丝分裂停滞和细胞凋亡

Joshua T Kowalczyk, Xiaolin Wan, Edjay R Hernandez, Ruibai Luo, Gaelyn C Lyons, Kelli M Wilson, Devorah C Gallardo, Kristine A Isanogle, Christina M Robinson, Arnulfo Mendoza, Christine M Heske, Jinqui-Qiu Chen, Xiaoling Luo, Alexander E Kelly, Simone Difilippantinio, Robert W Robey, Craig J Thomas,

MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma

MEK抑制诱导MYOG表达并重塑RAS驱动的横纹肌肉瘤中的超级增强子

Yohe, Marielle E; Gryder, Berkley E; Shern, Jack F; Song, Young K; Chou, Hsien-Chao; Sindiri, Sivasish; Mendoza, Arnulfo; Patidar, Rajesh; Zhang, Xiaohu; Guha, Rajarashi; Butcher, Donna; Isanogle, Kristine A; Robinson, Christina M; Luo, Xiaoling; Chen, Jin-Qiu; Walton, Ashley; Awasthi, Parirokh; Edmondson, Elijah F; Difilippantonio, Simone; Wei, Jun S; Zhao, Keji; Ferrer, Marc; Thomas, Craig J; Khan, Javed